These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 3538403

  • 61. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ, Dray L, Ardaillou N.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):686-92. PubMed ID: 1108283
    [No Abstract] [Full Text] [Related]

  • 62. [Changes in blood coagulation in glomerulonephritis].
    Robeva R, Belovezhdov N, Genova V.
    Vutr Boles; 1982 Dec 15; 21(6):1-7. PubMed ID: 6219496
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. [Diagnosis of the prethrombotic state in clinical practice].
    Makatsariia AD, Mishchenko AL.
    Sov Med; 1982 Dec 15; (6):56-60. PubMed ID: 6750807
    [No Abstract] [Full Text] [Related]

  • 65. [Relevance of fibrinogen/fibrin degradation products in the study of thrombosis].
    Páramo JA, Gaffney PJ.
    Sangre (Barc); 1989 Dec 15; 34(6):497-501. PubMed ID: 2697948
    [No Abstract] [Full Text] [Related]

  • 66. [Hemostatic changes related to anesthetic drugs and surgical intervention].
    Sparacia A, Mangione S, Sansone A.
    Minerva Anestesiol; 1980 Jul 15; 46(7):791-814. PubMed ID: 7017462
    [No Abstract] [Full Text] [Related]

  • 67. [Somatostatin and the hemostatic system (author's transl)].
    Hnidec O.
    Przegl Lek; 1980 Jul 15; 37(4):421-3. PubMed ID: 6105700
    [No Abstract] [Full Text] [Related]

  • 68. [Mechanism of fibrinolysis (review of the literature)].
    Kovalenko AN.
    Vrach Delo; 1983 Jan 15; (1):10-5. PubMed ID: 6223445
    [No Abstract] [Full Text] [Related]

  • 69. [Fibrinogen and fibrin degradation products].
    Fujimaki M, Ikematsu S, Kato M.
    Rinsho Byori; 1973 Jan 15; 21(1):31-6. PubMed ID: 4267650
    [No Abstract] [Full Text] [Related]

  • 70. Laboratory assessment of circulating anticoagulants.
    Armitage JB, Hernandez JA, Kaplan HS.
    Clin Lab Med; 1994 Dec 15; 14(4):795-812. PubMed ID: 7874872
    [Abstract] [Full Text] [Related]

  • 71. [Biological effect of fibrin/fibrinogen degradation products].
    Li SQ.
    Sheng Li Ke Xue Jin Zhan; 1986 Apr 15; 17(2):169-72. PubMed ID: 3538403
    [No Abstract] [Full Text] [Related]

  • 72. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ, Dray L, Ardaillou N.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):686-92. PubMed ID: 1108283
    [No Abstract] [Full Text] [Related]

  • 73. [Changes in blood coagulation in glomerulonephritis].
    Robeva R, Belovezhdov N, Genova V.
    Vutr Boles; 1982 Dec 15; 21(6):1-7. PubMed ID: 6219496
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. [Diagnosis of the prethrombotic state in clinical practice].
    Makatsariia AD, Mishchenko AL.
    Sov Med; 1982 Dec 15; (6):56-60. PubMed ID: 6750807
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [New Search]
    of 4.